AU2002355369A1 - Labelled conjugates of p17 protein and their use in aids diagnosis - Google Patents

Labelled conjugates of p17 protein and their use in aids diagnosis

Info

Publication number
AU2002355369A1
AU2002355369A1 AU2002355369A AU2002355369A AU2002355369A1 AU 2002355369 A1 AU2002355369 A1 AU 2002355369A1 AU 2002355369 A AU2002355369 A AU 2002355369A AU 2002355369 A AU2002355369 A AU 2002355369A AU 2002355369 A1 AU2002355369 A1 AU 2002355369A1
Authority
AU
Australia
Prior art keywords
protein
aids diagnosis
labelled conjugates
conjugates
labelled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002355369A
Inventor
Arnaldo Caruso
Simona Fiorentini
Jose Sebastian Franzone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medestea Internazionale SpA
Original Assignee
Medestea Internazionale SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2001TO000795A external-priority patent/ITTO20010795A1/en
Priority claimed from ITTO20011042 external-priority patent/ITTO20011042A1/en
Priority claimed from IT2002TO000278A external-priority patent/ITTO20020278A1/en
Application filed by Medestea Internazionale SpA filed Critical Medestea Internazionale SpA
Publication of AU2002355369A1 publication Critical patent/AU2002355369A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nanotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
AU2002355369A 2001-08-07 2002-08-05 Labelled conjugates of p17 protein and their use in aids diagnosis Abandoned AU2002355369A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
ITTO2001A000795 2001-08-07
IT2001TO000795A ITTO20010795A1 (en) 2001-08-07 2001-08-07 POLYPEPTIDE ISOLATED BASED ON THE SEQUENCE OF PROTEIN P17 USEFUL AS AN ANTI-HIV VACCINE.
ITTO20011042 ITTO20011042A1 (en) 2001-11-02 2001-11-02 ISOLATED POLYPEPTIDES BASED ON HIV PROTEIN P17 SEQUENCE USEFUL AS AN ANTI-HIV VACCINE.
ITTO2001A001042 2001-11-02
IT2002TO000278A ITTO20020278A1 (en) 2002-03-28 2002-03-28 PROCEDURE FOR THE IDENTIFICATION OF CELLS EXPRESSED ON ITS SURFACE A RECEPTOR FOR HIV-1 PROTEIN P17, AND PROTEIN P17
ITTO2002A000278 2002-03-28
PCT/IB2002/003092 WO2003014155A2 (en) 2001-08-07 2002-08-05 Labelled conjugates of p17 protein and their use in aids diagnosis

Publications (1)

Publication Number Publication Date
AU2002355369A1 true AU2002355369A1 (en) 2003-02-24

Family

ID=27274257

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002355369A Abandoned AU2002355369A1 (en) 2001-08-07 2002-08-05 Labelled conjugates of p17 protein and their use in aids diagnosis

Country Status (2)

Country Link
AU (1) AU2002355369A1 (en)
WO (1) WO2003014155A2 (en)

Also Published As

Publication number Publication date
WO2003014155A2 (en) 2003-02-20
WO2003014155A3 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
AU2001286171A1 (en) Human cDNAs and proteins and uses thereof
AU2001277172A1 (en) Bstp-trans protein and related reagents and methods of use thereof
AU2002230831A1 (en) Compositions of human proteins and method of use thereof
AU2001278011A1 (en) Bstp-ecg1 protein and related reagents and methods of use thereof
AU2002318482A1 (en) Quantitative in vitro bone induction assay
AU2001286721A1 (en) Human interleukin-four induced protein
AU2001274566A1 (en) Novel protein and dna thereof
AU2001263236A1 (en) Human myd88 adapter-like protein and functional fragments thereof
AU2002355369A1 (en) Labelled conjugates of p17 protein and their use in aids diagnosis
AU2001274309A1 (en) Phosphoglycan messengers and their medical uses
AU2001297556A1 (en) 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
AU2001280993A1 (en) Tissue-associated proteins and their uses
AU2001263287A1 (en) Human protein kinase "13305" and uses therefor
AU2001297794A1 (en) Methods and compositions of human proteins and uses thereof.
AU2002245158A1 (en) Human proteins 55562 and 21617, and methods of use thereof
AU2002360333A1 (en) Human angiomotin-like protein 1
AU2002357609A1 (en) Novel proteins and dnas thereof
AU2002230137A1 (en) Novel protein and use thereof
AU2002257630A1 (en) Human mrp5-like protein
AU2002226691A1 (en) Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby
AU2001274318A1 (en) Phosphoglycan messengers and their medical uses
AU2001245693A1 (en) Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
AU2002228882A1 (en) 58569 and 50111, human anion exchange proteins and methods of use thereof
AU2001282818A1 (en) Adhesive protein and uses thereof
AU2001297784A1 (en) 84242, 8035, 55304, 52999, and 21999, novel human proteins and methods of use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase